Results 21 to 30 of about 1,084,654 (294)
Background: Alzheimer’s disease (AD) is the most common cause of dementia, with a growing number of patients worldwide. The association between AD and treatment with drugs targeting the beta-adrenergic receptor is controversial.
Ali Alghamdi +5 more
doaj +1 more source
BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj +3 more sources
The effect of beta blockers on heart rate response during the Chester Step Test [PDF]
The objective of this study is to ascertain that as the intensity of exercise increases through the stages of the Chester Step Test (CST) does the difference between the beta blocked(BB) and the non beta blocked(NBB) participants heart rate(HR) response ...
Gilchrest, Joanne
core +2 more sources
Die Beta-Adrenerge blokkeermiddels
No abstract available.
Loubie Walters
doaj +1 more source
Beta blockers in traumatic brain injury: a systematic review and meta-analysis
Background Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Beta blockers have shown promise in improving mortality and functional outcomes after TBI. The aim of this article is to synthesize the available clinical data on
Andrew Chen +5 more
doaj +1 more source
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease [PDF]
<p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among ...
Abergel, Helene +66 more
core +1 more source
Background: Beta-blockers with additional beneficial activity such as beta-2 agonist and alpha-1 blocking activity are developed and available as the third-generation beta-blockers for effective management of hypertension with comorbid conditions ...
Haripriya Sadam, Subash K R
doaj +1 more source
Effect of prostaglandins and beta blockers on progression of hypertensive and normotensive glaucomas
Aim. The aim of the study was to evaluate the progression of changes in the visual fields in patients with hypertensive glaucoma (HTG) and normotensive glaucoma (NTG) following administration of prostaglandins and beta blockers, as well as also in NTG ...
Klara Maresova +3 more
core +1 more source
Background Beta-blockers are widely used for many cardiovascular conditions; however, their efficacy in contemporary clinical practice remains uncertain.
Oliver J. Ziff +6 more
doaj +1 more source
Background: Beta-blockers are preferred anti-hypertensive for patients with compelling indications. Vasodilator beta-blockers are of particular benefit in blood pressure control and other cardio-metabolic components with limited disturbance in metabolic
Mende Mensa Sorato +2 more
doaj

